Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 8/2018

03.03.2018 | Original Article

Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma

verfasst von: Sheng-Chieh Chan, Chih-Hua Yeh, Tzu-Chen Yen, Shu-Hang Ng, Joseph Tung-Chieh Chang, Chien-Yu Lin, Tsang Yen-Ming, Kang-Hsing Fan, Bing-Shen Huang, Cheng-Lung Hsu, Kai-Ping Chang, Hung-Ming Wang, Chun-Ta Liao

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Both head and neck magnetic resonance imaging (MRI) and 18F–fluorodeoxyglucose (18F–FDG) positron emission tomography (PET)/computed tomography (CT) play a crucial role in the staging of primary nasopharyngeal carcinoma (NPC). In this study, we sought to prospectively investigate the clinical utility of simultaneous whole-body 18F–FDG PET/MRI for primary staging of NPC patients.

Methods

We examined 113 patients with histologically confirmed NPC who underwent pretreatment, simultaneous whole-body PET/MRI and PET/CT for primary tumor staging. The images obtained with the different imaging modalities were interpreted independently and compared with each other.

Results

PET/MRI increased the accuracy of head and neck MRI for assessment of primary tumor extent in four patients via addition of FDG uptake information to increase the conspicuity of morphologically subtle lesions. PET/MR images were more discernible than PET/CT images for mapping tumor extension, especially intracranial invasion. Regarding the N staging assessment, the sensitivity of PET/MRI (99.5%) was higher than that of head and neck MRI (94.2%) and PET/CT (90.9%). PET/MRI was particularly useful for distinguishing retropharyngeal nodal metastasis from adjacent nasopharyngeal tumors. For distant metastasis evaluation, PET/MRI exhibited a similar sensitivity (90% vs. 86.7% vs. 83.3%), but higher positive predictive value (93.1% vs. 78.8% vs. 83.3%) than whole-body MRI and PET/CT, respectively.

Conclusions

For tumor staging of NPC, simultaneous whole-body PET/MRI was more accurate than head and neck MRI and PET/CT, and may serve as a single-step staging modality.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Queiroz MA, Huellner MW. PET/MR in cancers of the head and neck. Semin Nucl Med. 2015;45(3):248–65.CrossRefPubMed Queiroz MA, Huellner MW. PET/MR in cancers of the head and neck. Semin Nucl Med. 2015;45(3):248–65.CrossRefPubMed
2.
Zurück zum Zitat Spick C, Herrmann K, Czernin J. 18F-FDG PET/CT and PET/MRI perform equally well in cancer: evidence from studies on more than 2,300 patients. J Nucl Med. 2016;57(3):420–30.CrossRefPubMedPubMedCentral Spick C, Herrmann K, Czernin J. 18F-FDG PET/CT and PET/MRI perform equally well in cancer: evidence from studies on more than 2,300 patients. J Nucl Med. 2016;57(3):420–30.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Ng SH, Chang TC, Ko SF, Yen PS, Wan YL, Tang LM, et al. Nasopharyngeal carcinoma: MRI and CT assessment. Neuroradiology. 1997;39(10):741–6.CrossRefPubMed Ng SH, Chang TC, Ko SF, Yen PS, Wan YL, Tang LM, et al. Nasopharyngeal carcinoma: MRI and CT assessment. Neuroradiology. 1997;39(10):741–6.CrossRefPubMed
5.
Zurück zum Zitat Ng SH, Chan SC, Yen TC, Chang JT, Liao CT, Ko SF, et al. Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up. Eur J Nucl Med Mol Imaging. 2009;36(1):12–22.CrossRefPubMed Ng SH, Chan SC, Yen TC, Chang JT, Liao CT, Ko SF, et al. Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up. Eur J Nucl Med Mol Imaging. 2009;36(1):12–22.CrossRefPubMed
6.
Zurück zum Zitat Chang JT, Chan SC, Yen TC, Liao CT, Lin CY, Lin KJ, et al. Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys. 2005;62(2):501–7.CrossRefPubMed Chang JT, Chan SC, Yen TC, Liao CT, Lin CY, Lin KJ, et al. Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys. 2005;62(2):501–7.CrossRefPubMed
7.
Zurück zum Zitat Yen TC, Chang JT, Ng SH, Chang YC, Chan SC, Lin KJ, et al. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. J Nucl Med. 2005;46(3):405–10.PubMed Yen TC, Chang JT, Ng SH, Chang YC, Chan SC, Lin KJ, et al. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. J Nucl Med. 2005;46(3):405–10.PubMed
8.
Zurück zum Zitat Ng SH, Chan SC, Yen TC, Chang JT, Liao CT, Ko SF, et al. Pretreatment evaluation of distant-site status in patients with nasopharyngeal carcinoma: accuracy of whole-body MRI at 3-tesla and FDG-PET-CT. Eur Radiol. 2009;19(12):2965–76.CrossRefPubMed Ng SH, Chan SC, Yen TC, Chang JT, Liao CT, Ko SF, et al. Pretreatment evaluation of distant-site status in patients with nasopharyngeal carcinoma: accuracy of whole-body MRI at 3-tesla and FDG-PET-CT. Eur Radiol. 2009;19(12):2965–76.CrossRefPubMed
9.
Zurück zum Zitat Chua ML, Ong SC, Wee JT, Ng DC, Gao F, Tan TW, et al. Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma. Head Neck. 2009;31(3):346–54.CrossRefPubMed Chua ML, Ong SC, Wee JT, Ng DC, Gao F, Tan TW, et al. Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma. Head Neck. 2009;31(3):346–54.CrossRefPubMed
10.
Zurück zum Zitat Chang MC, Chen JH, Liang JA, Yang KT, Cheng KY, Kao CH. Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis. Eur J Radiol. 2013;82(2):366–73.CrossRefPubMed Chang MC, Chen JH, Liang JA, Yang KT, Cheng KY, Kao CH. Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis. Eur J Radiol. 2013;82(2):366–73.CrossRefPubMed
11.
Zurück zum Zitat Shen G, Zhang W, Jia Z, Li J, Wang Q, Deng H. Meta-analysis of diagnostic value of 18F-FDG PET or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma. Br J Radiol. 2014;87(1044):20140296.CrossRefPubMedPubMedCentral Shen G, Zhang W, Jia Z, Li J, Wang Q, Deng H. Meta-analysis of diagnostic value of 18F-FDG PET or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma. Br J Radiol. 2014;87(1044):20140296.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Ng SH, Chan SC, Yen TC, Liao CT, Chang JT, Ko SF, et al. Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT. Eur Radiol. 2010;20(9):2229–40.CrossRefPubMed Ng SH, Chan SC, Yen TC, Liao CT, Chang JT, Ko SF, et al. Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT. Eur Radiol. 2010;20(9):2229–40.CrossRefPubMed
13.
Zurück zum Zitat Jakoby BW, Bercier Y, Conti M, Casey ME, Bendriem B, Townsend DW. Physical and clinical performance of the mCT time-of-flight PET/CT scanner. Phys Med Biol. 2011;56(8):2375–89.CrossRefPubMed Jakoby BW, Bercier Y, Conti M, Casey ME, Bendriem B, Townsend DW. Physical and clinical performance of the mCT time-of-flight PET/CT scanner. Phys Med Biol. 2011;56(8):2375–89.CrossRefPubMed
14.
Zurück zum Zitat Delso G, Furst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med. 2011;52(12):1914–22.CrossRefPubMed Delso G, Furst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med. 2011;52(12):1914–22.CrossRefPubMed
15.
Zurück zum Zitat King AD, Ma BB, Yau YY, Zee B, Leung SF, Wong JK, et al. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis. Br J Radiol. 2008;81(964):291–8.CrossRefPubMed King AD, Ma BB, Yau YY, Zee B, Leung SF, Wong JK, et al. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis. Br J Radiol. 2008;81(964):291–8.CrossRefPubMed
16.
Zurück zum Zitat Chan SC, Wang HM, Yen TC, Lin CY, Chin SC, Liao CT, et al. (1)(8)F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study. Eur J Nucl Med Mol Imaging. 2011;38(9):1607–19.CrossRefPubMed Chan SC, Wang HM, Yen TC, Lin CY, Chin SC, Liao CT, et al. (1)(8)F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study. Eur J Nucl Med Mol Imaging. 2011;38(9):1607–19.CrossRefPubMed
17.
Zurück zum Zitat Kubiessa K, Purz S, Gawlitza M, Kuhn A, Fuchs J, Steinhoff KG, et al. Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancer. Eur J Nucl Med Mol Imaging. 2014;41(4):639–48.CrossRefPubMed Kubiessa K, Purz S, Gawlitza M, Kuhn A, Fuchs J, Steinhoff KG, et al. Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancer. Eur J Nucl Med Mol Imaging. 2014;41(4):639–48.CrossRefPubMed
18.
Zurück zum Zitat Kuhn FP, Hullner M, Mader CE, Kastrinidis N, Huber GF, von Schulthess GK, et al. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed? J Nucl Med. 2014;55(4):551–8.CrossRefPubMed Kuhn FP, Hullner M, Mader CE, Kastrinidis N, Huber GF, von Schulthess GK, et al. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed? J Nucl Med. 2014;55(4):551–8.CrossRefPubMed
19.
Zurück zum Zitat Platzek I, Beuthien-Baumann B, Schneider M, Gudziol V, Kitzler HH, Maus J, et al. FDG PET/MR for lymph node staging in head and neck cancer. Eur J Radiol. 2014;83(7):1163–8.CrossRefPubMed Platzek I, Beuthien-Baumann B, Schneider M, Gudziol V, Kitzler HH, Maus J, et al. FDG PET/MR for lymph node staging in head and neck cancer. Eur J Radiol. 2014;83(7):1163–8.CrossRefPubMed
20.
Zurück zum Zitat Queiroz MA, Hullner M, Kuhn F, Huber G, Meerwein C, Kollias S, et al. PET/MRI and PET/CT in follow-up of head and neck cancer patients. Eur J Nucl Med Mol Imaging. 2014;41(6):1066–75.PubMed Queiroz MA, Hullner M, Kuhn F, Huber G, Meerwein C, Kollias S, et al. PET/MRI and PET/CT in follow-up of head and neck cancer patients. Eur J Nucl Med Mol Imaging. 2014;41(6):1066–75.PubMed
21.
Zurück zum Zitat Queiroz MA, Hullner M, Kuhn F, Huber G, Meerwein C, Kollias S, et al. Use of diffusion-weighted imaging (DWI) in PET/MRI for head and neck cancer evaluation. Eur J Nucl Med Mol Imaging. 2014;41(12):2212–21.CrossRefPubMed Queiroz MA, Hullner M, Kuhn F, Huber G, Meerwein C, Kollias S, et al. Use of diffusion-weighted imaging (DWI) in PET/MRI for head and neck cancer evaluation. Eur J Nucl Med Mol Imaging. 2014;41(12):2212–21.CrossRefPubMed
22.
Zurück zum Zitat Schaarschmidt BM, Heusch P, Buchbender C, Ruhlmann M, Bergmann C, Ruhlmann V, et al. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI. Eur J Nucl Med Mol Imaging. 2016;43(1):92–102.CrossRefPubMed Schaarschmidt BM, Heusch P, Buchbender C, Ruhlmann M, Bergmann C, Ruhlmann V, et al. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI. Eur J Nucl Med Mol Imaging. 2016;43(1):92–102.CrossRefPubMed
23.
Zurück zum Zitat Covello M, Cavaliere C, Aiello M, Cianelli MS, Mesolella M, Iorio B, et al. Simultaneous PET/MR head-neck cancer imaging: preliminary clinical experience and multiparametric evaluation. Eur J Radiol. 2015;84(7):1269–76.CrossRefPubMed Covello M, Cavaliere C, Aiello M, Cianelli MS, Mesolella M, Iorio B, et al. Simultaneous PET/MR head-neck cancer imaging: preliminary clinical experience and multiparametric evaluation. Eur J Radiol. 2015;84(7):1269–76.CrossRefPubMed
24.
Zurück zum Zitat Cavaliere C, Romeo V, Aiello M, Mesolella M, Iorio B, Barbuto L, et al. Multiparametric evaluation by simultaneous PET-MRI examination in patients with histologically proven laryngeal cancer. Eur J Radiol. 2017;88:47–55.CrossRefPubMed Cavaliere C, Romeo V, Aiello M, Mesolella M, Iorio B, Barbuto L, et al. Multiparametric evaluation by simultaneous PET-MRI examination in patients with histologically proven laryngeal cancer. Eur J Radiol. 2017;88:47–55.CrossRefPubMed
25.
Zurück zum Zitat Ng SH, Chong VF, Ko SF, Mukherji SK. Magnetic resonance imaging of nasopharyngeal carcinoma. Top Magn Reson Imaging. 1999;10(5):290–303.CrossRefPubMed Ng SH, Chong VF, Ko SF, Mukherji SK. Magnetic resonance imaging of nasopharyngeal carcinoma. Top Magn Reson Imaging. 1999;10(5):290–303.CrossRefPubMed
26.
Zurück zum Zitat Hu WH, Zhang GY, Liu LZ, Wu HB, Li L, Gao YH, et al. Comparison between PET-CT and MRI in diagnosing nodal metastasis of nasopharyngeal carcinoma. Ai Zheng. 2005;24(7):855–60.PubMed Hu WH, Zhang GY, Liu LZ, Wu HB, Li L, Gao YH, et al. Comparison between PET-CT and MRI in diagnosing nodal metastasis of nasopharyngeal carcinoma. Ai Zheng. 2005;24(7):855–60.PubMed
27.
Zurück zum Zitat Zhang GY, Hu WH, Liu LZ, Wu HB, Gao YH, Li L, et al. Comparison between PET/CT and MRI in diagnosing lymph node metastasis and N staging of nasopharyngeal carcinoma. Zhonghua Zhong Liu Za Zhi. 2006;28(5):381–4.PubMed Zhang GY, Hu WH, Liu LZ, Wu HB, Gao YH, Li L, et al. Comparison between PET/CT and MRI in diagnosing lymph node metastasis and N staging of nasopharyngeal carcinoma. Zhonghua Zhong Liu Za Zhi. 2006;28(5):381–4.PubMed
28.
Zurück zum Zitat Yen TC, Chang YC, Chan SC, Chang JT, Hsu CH, Lin KJ, et al. Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes? Eur J Nucl Med Mol Imaging. 2005;32(5):541–8.CrossRefPubMed Yen TC, Chang YC, Chan SC, Chang JT, Hsu CH, Lin KJ, et al. Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes? Eur J Nucl Med Mol Imaging. 2005;32(5):541–8.CrossRefPubMed
29.
Zurück zum Zitat Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, et al. NCCN guidelines insights: head and neck cancers, version 2.2017. J Natl Compr Cancer Netw. 2017;15(6):761–70.CrossRef Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, et al. NCCN guidelines insights: head and neck cancers, version 2.2017. J Natl Compr Cancer Netw. 2017;15(6):761–70.CrossRef
30.
Zurück zum Zitat Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA. 2003;290(24):3199–206.CrossRefPubMed Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA. 2003;290(24):3199–206.CrossRefPubMed
31.
Zurück zum Zitat Ohno Y, Koyama H, Nogami M, Takenaka D, Yoshikawa T, Yoshimura M, et al. Whole-body MR imaging vs. FDG-PET: comparison of accuracy of M-stage diagnosis for lung cancer patients. J Magn Reson Imaging. 2007;26(3):498–509.CrossRefPubMed Ohno Y, Koyama H, Nogami M, Takenaka D, Yoshikawa T, Yoshimura M, et al. Whole-body MR imaging vs. FDG-PET: comparison of accuracy of M-stage diagnosis for lung cancer patients. J Magn Reson Imaging. 2007;26(3):498–509.CrossRefPubMed
32.
Zurück zum Zitat Pfannenberg C, Aschoff P, Schanz S, Eschmann SM, Plathow C, Eigentler TK, et al. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer. 2007;43(3):557–64.CrossRefPubMed Pfannenberg C, Aschoff P, Schanz S, Eschmann SM, Plathow C, Eigentler TK, et al. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer. 2007;43(3):557–64.CrossRefPubMed
33.
Zurück zum Zitat Squillaci E, Manenti G, Mancino S, Ciccio C, Calabria F, Danieli R, et al. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience. Abdom Imaging. 2008;33(6):676–88.CrossRefPubMed Squillaci E, Manenti G, Mancino S, Ciccio C, Calabria F, Danieli R, et al. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience. Abdom Imaging. 2008;33(6):676–88.CrossRefPubMed
34.
Zurück zum Zitat Yi CA, Shin KM, Lee KS, Kim BT, Kim H, Kwon OJ, et al. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. Radiology. 2008;248(2):632–42.CrossRefPubMed Yi CA, Shin KM, Lee KS, Kim BT, Kim H, Kwon OJ, et al. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. Radiology. 2008;248(2):632–42.CrossRefPubMed
35.
Zurück zum Zitat Itoh K, Saini S, Hahn PF, Imam N, Ferrucci JT. Differentiation between small hepatic hemangiomas and metastases on MR images: importance of size-specific quantitative criteria. AJR Am J Roentgenol. 1990;155(1):61–6.CrossRefPubMed Itoh K, Saini S, Hahn PF, Imam N, Ferrucci JT. Differentiation between small hepatic hemangiomas and metastases on MR images: importance of size-specific quantitative criteria. AJR Am J Roentgenol. 1990;155(1):61–6.CrossRefPubMed
36.
Zurück zum Zitat Schmidt GP, Haug AR, Schoenberg SO, Reiser MF. Whole-body MRI and PET-CT in the management of cancer patients. Eur Radiol. 2006;16(6):1216–25.CrossRefPubMed Schmidt GP, Haug AR, Schoenberg SO, Reiser MF. Whole-body MRI and PET-CT in the management of cancer patients. Eur Radiol. 2006;16(6):1216–25.CrossRefPubMed
37.
Zurück zum Zitat Stolzmann P, Veit-Haibach P, Chuck N, Rossi C, Frauenfelder T, Alkadhi H, et al. Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging. Investig Radiol. 2013;48(5):241–6.CrossRef Stolzmann P, Veit-Haibach P, Chuck N, Rossi C, Frauenfelder T, Alkadhi H, et al. Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging. Investig Radiol. 2013;48(5):241–6.CrossRef
38.
Zurück zum Zitat Lauenstein TC, Goehde SC, Herborn CU, Treder W, Ruehm SG, Debatin JF, et al. Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 minutes: a feasibility study. AJR Am J Roentgenol. 2002;179(2):445–9.CrossRefPubMed Lauenstein TC, Goehde SC, Herborn CU, Treder W, Ruehm SG, Debatin JF, et al. Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 minutes: a feasibility study. AJR Am J Roentgenol. 2002;179(2):445–9.CrossRefPubMed
39.
Zurück zum Zitat Hirsch FW, Sattler B, Sorge I, Kurch L, Viehweger A, Ritter L, et al. PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner. Pediatr Radiol. 2013;43(7):860–75.CrossRefPubMedPubMedCentral Hirsch FW, Sattler B, Sorge I, Kurch L, Viehweger A, Ritter L, et al. PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner. Pediatr Radiol. 2013;43(7):860–75.CrossRefPubMedPubMedCentral
Metadaten
Titel
Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma
verfasst von
Sheng-Chieh Chan
Chih-Hua Yeh
Tzu-Chen Yen
Shu-Hang Ng
Joseph Tung-Chieh Chang
Chien-Yu Lin
Tsang Yen-Ming
Kang-Hsing Fan
Bing-Shen Huang
Cheng-Lung Hsu
Kai-Ping Chang
Hung-Ming Wang
Chun-Ta Liao
Publikationsdatum
03.03.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 8/2018
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-018-3986-3

Weitere Artikel der Ausgabe 8/2018

European Journal of Nuclear Medicine and Molecular Imaging 8/2018 Zur Ausgabe